Novavax Inc vs Trade Desk Inc — how do they compare? Novavax Inc trades at $7.96 (market cap $1.31B), while Trade Desk Inc trades at $13.5 (market cap $6.37B). The key difference: Trade Desk Inc is far larger — about 4.9× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | TTD | |
|---|---|---|
Market Cap | $1.31B | $6.37B |
Sector | Health | Technology |
52-Week High | $11.19 | $55.36 |
52-Week Low | $6.22 | $13.39 |
Enterprise Value | $889.30M | $5.32B |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →